Login / Signup

Treatment of Ductal Carcinoma in Situ: Considerations for Tailoring Therapy in the Contemporary Era.

Anita MamtaniKimberly J VanZee
Published in: Current breast cancer reports (2020)
Estimation of LR risk, utilizing a multitude of clinicopathologic and treatment factors, can help a woman balance that risk with her values and priorities, and allow her to choose the optimal treatment option for her.
Keyphrases
  • stem cells
  • replacement therapy